Literature DB >> 20688547

Backtracking RAS mutations in high hyperdiploid childhood acute lymphoblastic leukemia.

Joseph L Wiemels1, Michelle Kang, Jeffrey S Chang, Lily Zheng, Carina Kouyoumji, Luoping Zhang, Martyn T Smith, Ghislaine Scelo, Catherine Metayer, Patricia Buffler, John K Wiencke.   

Abstract

High hyperdiploidy is the single largest subtype of childhood acute lymphoblastic leukemia (ALL) and is defined by the presence of 51-68 chromosomes in a karyotype. The 5 or more extra chromosomes characterizing this subtype are known to occur in a single mitotic event, prenatally. We screened for RAS mutations among 517 acute childhood leukemias (including 437 lymphocytic, of which 393 were B-cell subtypes) and found mutations in 30% of high hyperdiploids compared to only 10% of leukemias of other subtypes (P<0.0001). We assessed whether KRAS mutations occurred before birth using a PCR-restriction enzyme-mediated Taqman quantitative PCR reaction, and found no evidence for prenatal KRAS mutations in 14 patients tested. While RAS mutations were previously associated with prior chemical exposures in childhood and adult leukemias, in this study RAS-mutated cases were not significantly associated with parental smoking when compared to study controls. IGH rearrangements were backtracked in three RAS-positive patients (which were negative for KRAS mutation at birth) and found to be evident before birth, confirming a prenatal origin for the leukemia clone. We posit a natural history for hyperdiploid leukemia in which prenatal mitotic catastrophe is followed by a postnatal RAS mutation to produce the leukemic cell phenotype.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688547      PMCID: PMC2943008          DOI: 10.1016/j.bcmd.2010.07.007

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  26 in total

1.  Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: assay design and optimization.

Authors:  C J Fuery; H L Impey; N J Roberts; T L Applegate; R L Ward; N J Hawkins; C A Sheehan; R O'Grady; A V Todd
Journal:  Clin Chem       Date:  2000-05       Impact factor: 8.327

2.  Mutation of genes affecting the RAS pathway is common in childhood acute lymphoblastic leukemia.

Authors:  Marian Case; Elizabeth Matheson; Lynne Minto; Rosline Hassan; Christine J Harrison; Nick Bown; Simon Bailey; Josef Vormoor; Andrew G Hall; Julie A E Irving
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

3.  Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations.

Authors:  J Davidsson; K Paulsson; D Lindgren; H Lilljebjörn; T Chaplin; E Forestier; M K Andersen; A Nordgren; R Rosenquist; T Fioretos; B D Young; B Johansson
Journal:  Leukemia       Date:  2010-03-18       Impact factor: 11.528

4.  Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia.

Authors:  T Yagi; S Hibi; Y Tabata; K Kuriyama; T Teramura; T Hashida; Y Shimizu; T Takimoto; S Todo; T Sawada; S Imashuku
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

5.  High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia.

Authors:  Jeffrey W Taub; Mark A Konrad; Yubin Ge; John M Naber; Jackie S Scott; Larry H Matherly; Yaddanapudi Ravindranath
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

6.  PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia.

Authors:  Tomoko Yamamoto; Mariko Isomura; Yinyan Xu; Juan Liang; Hiroshi Yagasaki; Yoshiro Kamachi; Kazuko Kudo; Hitoshi Kiyoi; Tomoki Naoe; Seiji Kojma
Journal:  Leuk Res       Date:  2006-03-14       Impact factor: 3.156

7.  D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia.

Authors:  Ronald W Stam; Monique L den Boer; Pauline Schneider; Marrit Meier; H Berna Beverloo; Rob Pieters
Journal:  Haematologica       Date:  2007-11       Impact factor: 9.941

8.  Prenatal origin of childhood acute lymphoblastic leukemia, association with birth weight and hyperdiploidy.

Authors:  B Gruhn; J W Taub; Y Ge; J F Beck; R Zell; R Häfer; F H Hermann; K-M Debatin; D Steinbach
Journal:  Leukemia       Date:  2008-06-12       Impact factor: 11.528

9.  Residential exposures to pesticides and childhood leukaemia.

Authors:  Catherine Metayer; Patricia A Buffler
Journal:  Radiat Prot Dosimetry       Date:  2008-10-21       Impact factor: 0.972

10.  Chronic health conditions in adult survivors of childhood cancer.

Authors:  Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 176.079

View more
  16 in total

1.  Tobacco Smoke and Ras Mutations Among Latino and Non-Latino Children with Acute Lymphoblastic Leukemia.

Authors:  Maneet Kaur; Adam J de Smith; Steve Selvin; Luoping Zhang; Marc Cunningham; Michelle W Kang; Helen M Hansen; Robert M Cooper; Roberta McKean-Cowdin; Joseph L Wiemels; Catherine Metayer
Journal:  Arch Med Res       Date:  2016-11       Impact factor: 2.235

2.  Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemia.

Authors:  Kyle M Walsh; Adam J de Smith; Tara C Welch; Ivan Smirnov; Marc J Cunningham; Xiaomei Ma; Anand P Chokkalingam; Gary V Dahl; William Roberts; Lisa F Barcellos; Patricia A Buffler; Catherine Metayer; Joseph L Wiemels
Journal:  Am J Hematol       Date:  2014-04-18       Impact factor: 10.047

Review 3.  Genomics in acute lymphoblastic leukaemia: insights and treatment implications.

Authors:  Kathryn G Roberts; Charles G Mullighan
Journal:  Nat Rev Clin Oncol       Date:  2015-03-17       Impact factor: 66.675

Review 4.  Philadelphia Chromosome-like Acute Lymphoblastic Leukemia.

Authors:  Ching-Hon Pui; Kathryn G Roberts; Jun J Yang; Charles G Mullighan
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2017-08

Review 5.  Perspectives on the causes of childhood leukemia.

Authors:  Joseph Wiemels
Journal:  Chem Biol Interact       Date:  2012-02-02       Impact factor: 5.192

6.  Childhood Leukemia and Primary Prevention.

Authors:  Todd P Whitehead; Catherine Metayer; Joseph L Wiemels; Amanda W Singer; Mark D Miller
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2016-10

7.  FLT3 mutation incidence and timing of origin in a population case series of pediatric leukemia.

Authors:  Patrick Chang; Michelle Kang; Anny Xiao; Jeffrey Chang; James Feusner; Patricia Buffler; Joseph Wiemels
Journal:  BMC Cancer       Date:  2010-09-27       Impact factor: 4.430

8.  PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia.

Authors:  Jianqiao Xiao; Seung-Tae Lee; Yuanyuan Xiao; Xiaomei Ma; E Andres Houseman; Ling-I Hsu; Ritu Roy; Margaret Wrensch; Adam J de Smith; Anand Chokkalingam; Patricia Buffler; John K Wiencke; Joseph L Wiemels
Journal:  Int J Cancer       Date:  2014-02-19       Impact factor: 7.396

9.  Evolutionary trajectories of hyperdiploid ALL in monozygotic twins.

Authors:  C M Bateman; D Alpar; A M Ford; S M Colman; D Wren; M Morgan; L Kearney; M Greaves
Journal:  Leukemia       Date:  2014-06-04       Impact factor: 11.528

10.  Ras pathway mutations are prevalent in relapsed childhood acute lymphoblastic leukemia and confer sensitivity to MEK inhibition.

Authors:  Julie Irving; Elizabeth Matheson; Lynne Minto; Helen Blair; Marian Case; Christina Halsey; Isabella Swidenbank; Frida Ponthan; Renate Kirschner-Schwabe; Stefanie Groeneveld-Krentz; Jana Hof; James Allan; Christine Harrison; Josef Vormoor; Arend von Stackelberg; Cornelia Eckert
Journal:  Blood       Date:  2014-09-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.